Related Experiment Video
Updated: Dec 26, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Factors influencing left ventricular ejection fraction in patients with coronary microvascular disease and
Henry Anselmo Mayala1, Magesa Mafuru2, Abdalah Mkangala3
1Jakaya Kikwete Cardiac Institute, P. O. Box 65141, West Upanga, Kalenga Street, Ilala District, Dar es Salaam, Tanzania. henrymayala@yahoo.co.uk.
Insights
In patients with coronary microvascular disease, left ventricular ejection fraction is negatively impacted by low-density lipoprotein and B-type natriuretic peptide. Coronary flow reserve positively correlates with left ventricular ejection fraction.
Area of Science:
- Cardiology
- Internal Medicine
- Biochemistry
Background:
- Coronary microvascular disease (CMD) and obstructive coronary artery disease (CAD) significantly impact cardiac function.
- Left ventricular ejection fraction (LVEF) is a key indicator of heart health, but its determinants in CMD are complex.
Purpose of the Study:
- To investigate the relationships between LVEF and biomarkers like low-density lipoprotein (LDL), B-type natriuretic peptide (BNP), Troponin I, and coronary flow reserve (CFR).
- To identify predictors of LVEF in patients with CMD, both with and without obstructive CAD.
Main Methods:
- Retrospective analysis of patient data including LVEF, LDL, BNP, Troponin I, and CFR.
- Statistical evaluation to determine correlations and predictive factors for LVEF.
Main Results:
- In patients with both obstructive CAD and CMD, LVEF showed inverse relationships with LDL, BNP, and Troponin I, but a direct relationship with CFR.
- In patients with obstructive CAD only, LVEF was negatively associated with LDL and BNP.
- Predictors of LVEF in CMD patients included age, blood pressure, lipids, red cell distribution width, HbA1c, symptoms, NYHA class, alcohol use, hypertension, diabetes, Troponin I, and BNP levels.
Conclusions:
- Biomarkers like LDL, BNP, and Troponin I are associated with reduced LVEF in CMD patients.
- CFR is a positive correlate of LVEF in patients with combined CMD and obstructive CAD.
- A multifactorial approach is needed to predict and manage LVEF in patients with CMD.
Objective:
The aim of our research was to evaluate the relationship involving left ventricular ejection fraction, low density lipoprotein, B-type natriuretic peptide, Troponin I and coronary flow reserve, and to determine the predictors of left ventricular ejection fraction in patients with coronary microvascular disease and obstructive coronary artery disease, and in patients with coronary microvascular disease.
Results:
The mean age was 58.5 ± 12.5 years. In patients with obstructive coronary disease and coronary microvascular disease we found low density lipoprotein-c had significant inverse relationship with left ventricular ejection fraction, left ventricular ejection fraction also had significant negative relationship with B-type natriuretic peptide, and Troponin-I. While a significant direct relationship turned out to be observed linking left ventricular ejection fraction with coronary flow reserve. Left ventricular ejection fraction had significant negative relationship with low density lipoprotein, and B-type natriuretic peptide in patients with obstructive coronary artery disease only. Age, blood pressure, lipid levels, red cell distribution width, glycated hemoglobin, symptoms, New York heart association classification, alcohol drinking, hypertension, diabetes mellitus, troponin levels and B-type natriuretic peptide were the predictors for left ventricular ejection fraction in coronary microvascular disease patients.
More Related Videos
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Mitral Stenosis I: Introduction
Pathophysiology of Cardiac Performance
Coronary Artery Disease II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction

